News Focus
News Focus
icon url

lasers

04/21/16 4:09 PM

#195567 RE: lasers #195563

$ELTP ELI-201 and ELI-202 in Pivotal Bio-Equivalence studies and will soon be submitted for FDA Branded approvals.


http://www.elitepharma.com/pipeline-branded/
icon url

Don'tDrinkTheKoolAid

04/21/16 4:09 PM

#195569 RE: lasers #195563

38.00 Eltp can't even get to .38 Lol
icon url

IB_

04/21/16 4:11 PM

#195571 RE: lasers #195563

Elite will NEVER hit $38.00 per share without a major Reverse Split !!!!

NEXT


IB_ ;)
icon url

lasers

04/23/16 11:04 AM

#195974 RE: lasers #195563

$ELTP at $38 PPS, with ELI-200 and their other ADFs achieving 20% share of the $12 bil opioid market is doable with a PE=40 in the 2016/2018 time frame. Based on fully diluted 1 billion shs.
$ELTP at $19 PPS, with ELI-200 achieving 10% market share.

$ELTP at $9-$10 PPS, with ELI-200 achieving 5% market share.

$ELTP at $4-$5 PPS, with ELI-200 achieving 2-3% market share.


###

So what happens to the PPS when $ELTP ADFs are marketed into the $40 to 50 billion Opioids Global Markets !!!!!!!!

###

Meanwhile for those that think PE=40 is high take a good look! at these Major Pharmas

BMY PE=74
MRK PE=36
PFE PE=29
REGN PE=76

###

$ELTP next ADFs ELI-201 and ELI-202 are officially Branded products in $ELTP Pipeline and currently in Pivotal Bio-equivalence studies/trials. $ELTP going for their own NDA 505B2 and the BIG BIG$$$$$. $18 to $20 per 80 mg capsule. 12 HR ER Morphine/Naltrexone or 12 HR ER Hydrocodone/Naltrexone or 12 HR ER Oxycodone/Naltrexone!!!!! etc. etc.